Our Services

Divergene works closely with CDMOs and gene therapy companies to support their next-generation sequencing capability from upstream vector engineering to downstream vector QC

technology, business, analysis-7111799.jpg

Custom NGS Analysis Pipeline Development

We’re experts on bioinformatics software; if you want something built, you probably want us. And we will deliver.

1. Do you need software to support your sequencing platform?

2. Do you need software that performs custom analysis of NGS data?

3. Do you need software that manages existing bioinformatics workflows?

4. Do you need your existing bioinformatics workflows tested and/or standardized?

5. Do you need to make your software clinical-grade for FDA submission or backed by escrow agent ?

If you answered yes to one or more of these questions, get in touch with us.

End-to-end Sequencing

Whether you are looking for AAV capsid library enrichment or interested in post-infection solutions, Divergene utilizes the latest technologies on the market, including PacBio® long-read (>10kb) and Illumina® short-read sequencing, to provide custom, in-depth solutions for complex AAV gene therapy applications.

  • Vector Discovery
  • Confirm Plasmid Sequences
  • Quantify AAV Expression

  • Validate Packaged Material

  • Monitor Host Response

  • Single Cell Sequencing
  • Transcriptome Analysis

If any of the applications interest you, get in touch with us.

Why Choose Us

Superior Speed & Data Quality

Robust framework, stringent quality control producing high-quality data

Ph.D.-Level Support

From start to finish, our experienced team provides insight and responses within hours

Customized solutions

From wet lab to dry lab, we provide support at every level and actionable dashboards/reports

cell & gene therapy focus

Trusted partner for top cell and gene therapy biotechs and biopharma


Divergene utilizes Illumina and other cutting-edge NGS platforms. For information on our NGS platforms as well as recommended configurations of your projects, please contact us.

Contact Us